» Articles » PMID: 16790655

Functional Magnetic Resonance Imaging Measures of the Effects of Morphine on Central Nervous System Circuitry in Opioid-naive Healthy Volunteers

Overview
Journal Anesth Analg
Specialty Anesthesiology
Date 2006 Jun 23
PMID 16790655
Citations 59
Authors
Affiliations
Soon will be listed here.
Abstract

In this pilot study, we used functional magnetic resonance imaging (fMRI) to study the effects of morphine in 8 healthy, opioid-naïve volunteers. Intravenous small-dose morphine (4 mg/70 kg) or saline was administered to volunteers undergoing a fMRI scan. Infusion of morphine, but not saline, elicited mild euphoria without aversive symptoms and resulted in positive signal changes in reward structures including the nucleus accumbens, sublenticular extended amygdala, orbitofrontal cortex, and hippocampus. The positive signal in the accumbens was opposite to the signal previously reported for noxious stimuli. Morphine produces a decreased signal in cortical areas in a similar manner to sedative-hypnotic drugs such as propofol or midazolam. Activation in endogenous analgesic regions was observed in the periaqueductal gray, the anterior cingulate gyrus (decreased signal), and hypothalamus (increased signals). The pattern of activation in reward circuitry was similar to that reported for euphoric drugs of abuse, providing a model to evaluate the initial effects of morphine on the central nervous system components of the circuitry involved in addiction. The segregation of fMRI response that was observed in cortical versus subcortical regions suggests a dissociation of reward from sensory-motor and cognitive functions. Activation patterns were opposite to those previously observed for the mu antagonist, naloxone.

Citing Articles

Explainable fNIRS-based pain decoding under pharmacological conditions via deep transfer learning approach.

Eken A, Yuce M, Yukselen G, Erdogan S Neurophotonics. 2024; 11(4):045015.

PMID: 39691581 PMC: 11651663. DOI: 10.1117/1.NPh.11.4.045015.


Mapping functional traces of opioid memories in the rat brain.

Gomes-Ribeiro J, Martins J, Sereno J, Deslauriers-Gauthier S, Summavielle T, Coelho J Brain Commun. 2024; 6(5):fcae281.

PMID: 39229487 PMC: 11369824. DOI: 10.1093/braincomms/fcae281.


Effects of chronic naltrexone treatment on relapse-related behavior and neural responses to fentanyl in awake nonhuman primates.

Withey S, Deshpande H, Cao L, Bergman J, Kohut S Psychopharmacology (Berl). 2024; 241(11):2289-2302.

PMID: 39122918 DOI: 10.1007/s00213-024-06633-6.


Unveiling Morphine: A Rapid and Selective Fluorescence Sensor for Forensic and Medical Analysis.

Boroujerdi R, Butt A, Paul R, Majumder S Sensors (Basel). 2024; 24(6).

PMID: 38543983 PMC: 10974434. DOI: 10.3390/s24061722.


The Role of fMRI in Drug Development: An Update.

Carmichael O Adv Neurobiol. 2023; 30:299-333.

PMID: 36928856 DOI: 10.1007/978-3-031-21054-9_13.